BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fernandez-Fernandez B, D'Marco L, Górriz JL, Jacobs-Cachá C, Kanbay M, Luis-Lima S, Porrini E, Sarafidis P, Soler MJ, Ortiz A. Exploring Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors for Organ Protection in COVID-19. J Clin Med 2020;9:E2030. [PMID: 32605278 DOI: 10.3390/jcm9072030] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 D’marco L. Diabetic Kidney Disease and Covid-19. Diabetes and Kidney Disease 2022. [DOI: 10.1007/978-3-030-86020-2_20] [Reference Citation Analysis]
2 Reshad RAI, Riana SH, Chowdhury MA, Moin AT, Miah F, Sarkar B, Jewel NA. Diabetes in COVID-19 patients: challenges and possible management strategies. Egypt J Bronchol 2021;15. [DOI: 10.1186/s43168-021-00099-2] [Reference Citation Analysis]
3 Hu S, Jiang S, Qi X, Bai R, Ye XY, Xie T. Races of small molecule clinical trials for the treatment of COVID-19: An up-to-date comprehensive review. Drug Dev Res 2021. [PMID: 34762760 DOI: 10.1002/ddr.21895] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
4 Farshidfar F, Koleini N, Ardehali H. Cardiovascular complications of COVID-19. JCI Insight 2021;6:148980. [PMID: 34061779 DOI: 10.1172/jci.insight.148980] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 27.0] [Reference Citation Analysis]
5 Rajpal A, Sayyed Kassem L, Aron DC. Management of diabetes in elderly patients during the COVID-19 pandemic: current and future perspectives. Expert Rev Endocrinol Metab 2021;16:181-9. [PMID: 34096441 DOI: 10.1080/17446651.2021.1927708] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
6 Shen L, Yang H, Fang X, Huang H, Yao W, Chen D, Shen Y. A Clinical Study on the Association of Sodium-Glucose Cotransporter 2 Inhibitors and Acute Kidney Injury Among Diabetic Chinese Population. Diabetes Metab Syndr Obes 2021;14:1621-30. [PMID: 33880048 DOI: 10.2147/DMSO.S300494] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Yi Y, Xu Y, Jiang H, Wang J. Cardiovascular Disease and COVID-19: Insight From Cases With Heart Failure. Front Cardiovasc Med 2021;8:629958. [PMID: 33791346 DOI: 10.3389/fcvm.2021.629958] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Gregório P, da Cunha RS, Biagini G, Bosquetti B, Budag J, Ortiz A, Sánchez-Niño MD, Barreto FC, Stinghen AEM. Chloroquine may induce endothelial injury through lysosomal dysfunction and oxidative stress. Toxicol Appl Pharmacol 2021;414:115412. [PMID: 33484708 DOI: 10.1016/j.taap.2021.115412] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
9 Kosiborod M, Berwanger O, Koch GG, Martinez F, Mukhtar O, Verma S, Chopra V, Javaheri A, Ambery P, Gasparyan SB, Buenconsejo J, Sjöström CD, Langkilde AM, Oscarsson J, Esterline R. Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID-19: Design and rationale for the DARE-19 study. Diabetes Obes Metab 2021;23:886-96. [PMID: 33319454 DOI: 10.1111/dom.14296] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 27.0] [Reference Citation Analysis]
10 Abu-Farha M, Al-Mulla F, Thanaraj TA, Kavalakatt S, Ali H, Abdul Ghani M, Abubaker J. Impact of Diabetes in Patients Diagnosed With COVID-19. Front Immunol 2020;11:576818. [PMID: 33335527 DOI: 10.3389/fimmu.2020.576818] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 18.0] [Reference Citation Analysis]
11 Delre P, Caporuscio F, Saviano M, Mangiatordi GF. Repurposing Known Drugs as Covalent and Non-covalent Inhibitors of the SARS-CoV-2 Papain-Like Protease. Front Chem 2020;8:594009. [PMID: 33304884 DOI: 10.3389/fchem.2020.594009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 14.0] [Reference Citation Analysis]
12 Fang J, Genco M, Caskey RN. COVID-19 Precipitating Euglycaemic Diabetic Ketoacidosis with SGLT2 Inhibitor Use. Eur J Case Rep Intern Med 2020;7:001943. [PMID: 33194873 DOI: 10.12890/2020_001943] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
13 Fernandez-Prado R, Gonzalez-Parra E, Ortiz A. Often forgotten, transport modality to dialysis may be life-saving. Clin Kidney J 2020;13:510-2. [PMID: 32905336 DOI: 10.1093/ckj/sfaa163] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]